Clinical Trial Update: The Treatment of PD-1 Antibody Combined With Peg-IFNα in NAs-suppressed CHB Patients [NA]

View source ↗

Summary

Clinical trial update on a PD-1 antibody combined with Peg-IFNα in hepatitis B patients whose nucleos(t)ide analog therapy is suppressed. The study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• PD-1 antibody (PD-1 inhibitor)
• Pegylated interferon alpha (Pegylated interferon alfa)

Snippet

Sponsor: Beijing 302 Hospital | Conditions: Chronic Hepatitis B | NA | Status: ACTIVE_NOT_RECRUITING